---
name: NeurIPS 2026 feasibility review
description: Comprehensive acceptance feasibility assessment of the full paper as of 2026-04-12
type: project
---

# NeurIPS 2026 Feasibility Review (2026-04-12)

**Overall Score: 4.5-5.5/10 (borderline to weak reject)**
**Estimated reviewer scores: 4, 5, 5 (reject)**

## Key Verdict
- Clean conceptual insight (decoupled monitoring enables boosting) is genuine and novel
- Empirical evidence concentrated on CREMA-D only; other 5 benchmarks show marginal/no improvement
- No theory, missing abstract/discussion, overclaims in introduction
- With Tier 1+2 fixes: could reach 5,5,6 (borderline accept)
- Path to clear accept requires stronger standalone results or meaningful theory

## Critical Weaknesses (Rejection Drivers)
1. Boost-only barely helps on flagship CREMA-D (+1.13pp); method needs OGM-GE to work
2. "Consistent improvements across all six" is an overclaim (MOSEI/MOSI: OGM-GE >= method)
3. No statistical significance tests
4. No theoretical analysis (purely heuristic)
5. Discussion/conclusion/abstract all empty
6. K-sweep and HP sensitivity data exists but not in manuscript

## Fix Priority
- Tier 1 (must-do): abstract, discussion, fix overclaims, stat tests, K-sweep in appendix, std standardization
- Tier 2 (strongly recommended): convergence sketch, BraTS OGM-GE, probe trajectories, MSLR distinction
- Tier 3 (would help): timing table, CGGM separation, 3-frame ablation, fill Table 1 gaps

**Why:** Pre-submission assessment to guide final revision priorities.
**How to apply:** Reference when advising on paper revisions or submission strategy.
